These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The acceptability of current contraceptive methods to adolescents].
    Author: Sotnikova EI, Dubnitskaia LV, Perminova SG.
    Journal: Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682.
    Abstract:
    The authors analyze the admissibility of present-day contraception methods in 107 adolescent girls who used oral anteovin and trisiston and in 128 ones who used copper-containing IUDs. Analysis has not revealed noticeable differences in the incidence of side effects in adolescents and a control group of women of a reproductive age. Spontaneous menses recovery occurred in all young patients within 26 to 36 days after the drugs were discontinued, and basal temperature biphasic pattern recovered in 70.2% of girls by the third month after IUD contraception discontinuation. Short courses (up to 6-12 months) of hormonal contraception are advisable for adolescents. IUD contraception complications presenting as expulsions and menstrual cycle disorders were 1.5-2 times more incident in the adolescents than in control women despite the preventive measures taken. A total of 235 adolescents aged 15-20 years were investigated, of whom 107 (Group I) were using oral contraceptives (OCs) (Trisiston and Anteovin) and 128 (Group II) were using IUDs containing copper: Cu 7-mini, Medusa, and T Cu 200. In addition, 215 women aged 20-35 years were studied in two more groups: 115 were using the OCs Anteovin and Trikvilar (Group III) and 100 were using the IUDs T Cu 200, Cu 7-Standard, and Medusa 1, 2, and 3 (Group IV). The reliability of OCs proved to be complete without even one unplanned pregnancy, while there were 4 such cases in Group II and 3 cases in Group IV. Side effects affected 9.3% among women using OCs in Groups I and III compared to only 7.5% in women at the midpoint of reproductive age. Group I experienced dyspepsia, reduction of work performance, and change in libido, while Group III experienced mammary tension and intermenstrual bleeding. 94.4% of patients in Group I and 94.6% of women in Group III had a menstrual cycle of 28.1 +or- 0.6 days at the beginning of OC use; compared to 27-29 days after the first cycle under OC treatment. Premenstrual syndrome and oligomenorrhea were found in 46.7% of adolescents using OCs and 12.3% of adult OC users at the beginning of treatment; however, by the third month of use menstrual disorders disappeared in all patients, and premenstrual syndrome as well as mammary tension occurred 2-5 days before menstruation in only 2.6% of women in Group III. Among IUD users complications were reported in 9.4% of Group II and 6.3% of Group IV. The frequency of expulsion was around 1.2-2.2 (mean 1.53) per 100 women in the course of 1 year in the adolescent users and 0.67 in Group IV patients. After 4 months of IUD use 73% of adolescents and 80% of women in Group IV experienced bleeding, while IUD removal because of hyperpolymenorrhea had to be done in 1.2% of Group II and 0.7% of Group IV users.
    [Abstract] [Full Text] [Related] [New Search]